Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSGEP | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | STK17B | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | POLR3GL | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | YEATS2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | PUDP | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | DISP2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | TCEB3B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | GSE1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | SLC35E2B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | NAT16 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |